The global Natural Killer Cell Therapy market is projected to grow from US$ 323 million in 2024 to US$ 1185.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 24.2% during the forecast period.

Natural Killer Cell Therapy Market

Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.

Market Analysis and Insights: Global Natural Killer Cell Therapy Market

The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.

Based on application, the market is classified into cancer, gastrointestinal diseases and others. The cancer segment accounted for a major share in 2019 (66.99%).

Major players operating in the market include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, NantWorks, Nkarta Therapeutics and etc. The Top 6 players accounted for 96.66% of the global revenue market share in 2019.

Report Covers:

This report presents an overview of global market for Natural Killer Cell Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Natural Killer Cell Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Natural Killer Cell Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Natural Killer Cell Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Natural Killer Cell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Natural Killer Cell Therapy revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Natural Killer Cell Therapy Market Report

Report Metric	Details
Report Name	Natural Killer Cell Therapy Market
Accounted market size in 2024	US$ 323 million
Forecasted market size in 2030	US$ 1185.5 million
CAGR	24.2
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	NK Cell Therapies NK Cell Directed Antibodies
Segment by Application	Cancer Gastrointestinal Diseases Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Glycostem Therapeutics, Fate Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, Nkarta Therapeutics, NantKwest
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Natural Killer Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Natural Killer Cell Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Natural Killer Cell Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Natural Killer Cell Therapy Market growing?

Ans: The Natural Killer Cell Therapy Market witnessing a CAGR of 24.2 during the forecast period 2024-2030.

What is the Natural Killer Cell Therapy Market size in 2030?

Ans: The Natural Killer Cell Therapy Market size in 2030 will be US$ 1185.5 million.

What is the Natural Killer Cell Therapy Market share by region?

Ans: The Americas natural killer cells therapeutics market share accounted for the highest share 52.3% in 2019.

What is the Natural Killer Cell Therapy Market share by application?

Ans: The cancer segment accounted for a major share in 2019 (66.99%).

What is the market share of major companies in Natural Killer Cell Therapy Market?

Ans: The Top 6 players accounted for 96.66% of the global revenue market share in 2019.

Who are the main players in the Natural Killer Cell Therapy Market report?

Ans: The main players in the Natural Killer Cell Therapy Market are Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Glycostem Therapeutics, Fate Therapeutics, Dragonfly Therapeutics, Kiadis Pharma, Nkarta Therapeutics, NantKwest

What are the Application segmentation covered in the Natural Killer Cell Therapy Market report?

Ans: The Applications covered in the Natural Killer Cell Therapy Market report are Cancer, Gastrointestinal Diseases, Others

What are the Type segmentation covered in the Natural Killer Cell Therapy Market report?

Ans: The Types covered in the Natural Killer Cell Therapy Market report are NK Cell Therapies, NK Cell Directed Antibodies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Natural Killer Cell Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 NK Cell Therapies

1.2.3 NK Cell Directed Antibodies

1.3 Market by Application

1.3.1 Global Natural Killer Cell Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Cancer

1.3.3 Gastrointestinal Diseases

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Natural Killer Cell Therapy Market Perspective (2019-2030)

2.2 Global Natural Killer Cell Therapy Growth Trends by Region

2.2.1 Natural Killer Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Natural Killer Cell Therapy Historic Market Size by Region (2019-2024)

2.2.3 Natural Killer Cell Therapy Forecasted Market Size by Region (2025-2030)

2.3 Natural Killer Cell Therapy Market Dynamics

2.3.1 Natural Killer Cell Therapy Industry Trends

2.3.2 Natural Killer Cell Therapy Market Drivers

2.3.3 Natural Killer Cell Therapy Market Challenges

2.3.4 Natural Killer Cell Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Natural Killer Cell Therapy by Players

3.1.1 Global Natural Killer Cell Therapy Revenue by Players (2019-2024)

3.1.2 Global Natural Killer Cell Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Natural Killer Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Natural Killer Cell Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Natural Killer Cell Therapy Market Concentration Ratio

3.4.1 Global Natural Killer Cell Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cell Therapy Revenue in 2023

3.5 Global Key Players of Natural Killer Cell Therapy Head office and Area Served

3.6 Global Key Players of Natural Killer Cell Therapy, Product and Application

3.7 Global Key Players of Natural Killer Cell Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Natural Killer Cell Therapy Breakdown Data by Type

4.1 Global Natural Killer Cell Therapy Historic Market Size by Type (2019-2024)

4.2 Global Natural Killer Cell Therapy Forecasted Market Size by Type (2025-2030)

5 Natural Killer Cell Therapy Breakdown Data by Application

5.1 Global Natural Killer Cell Therapy Historic Market Size by Application (2019-2024)

5.2 Global Natural Killer Cell Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Natural Killer Cell Therapy Market Size (2019-2030)

6.2 North America Natural Killer Cell Therapy Market Size by Type

6.2.1 North America Natural Killer Cell Therapy Market Size by Type (2019-2024)

6.2.2 North America Natural Killer Cell Therapy Market Size by Type (2025-2030)

6.2.3 North America Natural Killer Cell Therapy Market Share by Type (2019-2030)

6.3 North America Natural Killer Cell Therapy Market Size by Application

6.3.1 North America Natural Killer Cell Therapy Market Size by Application (2019-2024)

6.3.2 North America Natural Killer Cell Therapy Market Size by Application (2025-2030)

6.3.3 North America Natural Killer Cell Therapy Market Share by Application (2019-2030)

6.4 North America Natural Killer Cell Therapy Market Size by Country

6.4.1 North America Natural Killer Cell Therapy Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Natural Killer Cell Therapy Market Size by Country (2019-2024)

6.4.3 North America Natural Killer Cell Therapy Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Natural Killer Cell Therapy Market Size (2019-2030)

7.2 Europe Natural Killer Cell Therapy Market Size by Type

7.2.1 Europe Natural Killer Cell Therapy Market Size by Type (2019-2024)

7.2.2 Europe Natural Killer Cell Therapy Market Size by Type (2025-2030)

7.2.3 Europe Natural Killer Cell Therapy Market Share by Type (2019-2030)

7.3 Europe Natural Killer Cell Therapy Market Size by Application

7.3.1 Europe Natural Killer Cell Therapy Market Size by Application (2019-2024)

7.3.2 Europe Natural Killer Cell Therapy Market Size by Application (2025-2030)

7.3.3 Europe Natural Killer Cell Therapy Market Share by Application (2019-2030)

7.4 Europe Natural Killer Cell Therapy Market Size by Country

7.4.1 Europe Natural Killer Cell Therapy Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Natural Killer Cell Therapy Market Size by Country (2019-2024)

7.4.3 Europe Natural Killer Cell Therapy Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Natural Killer Cell Therapy Market Size (2019-2030)

8.2 China Natural Killer Cell Therapy Market Size by Type

8.2.1 China Natural Killer Cell Therapy Market Size by Type (2019-2024)

8.2.2 China Natural Killer Cell Therapy Market Size by Type (2025-2030)

8.2.3 China Natural Killer Cell Therapy Market Share by Type (2019-2030)

8.3 China Natural Killer Cell Therapy Market Size by Application

8.3.1 China Natural Killer Cell Therapy Market Size by Application (2019-2024)

8.3.2 China Natural Killer Cell Therapy Market Size by Application (2025-2030)

8.3.3 China Natural Killer Cell Therapy Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Natural Killer Cell Therapy Market Size (2019-2030)

9.2 Asia Natural Killer Cell Therapy Market Size by Type

9.2.1 Asia Natural Killer Cell Therapy Market Size by Type (2019-2024)

9.2.2 Asia Natural Killer Cell Therapy Market Size by Type (2025-2030)

9.2.3 Asia Natural Killer Cell Therapy Market Share by Type (2019-2030)

9.3 Asia Natural Killer Cell Therapy Market Size by Application

9.3.1 Asia Natural Killer Cell Therapy Market Size by Application (2019-2024)

9.3.2 Asia Natural Killer Cell Therapy Market Size by Application (2025-2030)

9.3.3 Asia Natural Killer Cell Therapy Market Share by Application (2019-2030)

9.4 Asia Natural Killer Cell Therapy Market Size by Region

9.4.1 Asia Natural Killer Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Natural Killer Cell Therapy Market Size by Region (2019-2024)

9.4.3 Asia Natural Killer Cell Therapy Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Size by Type

10.2.1 Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Size by Application

10.3.1 Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Size by Country

10.4.1 Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Nektar Therapeutics

11.1.1 Nektar Therapeutics Company Details

11.1.2 Nektar Therapeutics Business Overview

11.1.3 Nektar Therapeutics Natural Killer Cell Therapy Introduction

11.1.4 Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2019-2024)

11.1.5 Nektar Therapeutics Recent Developments

11.2 Innate Pharma SA

11.2.1 Innate Pharma SA Company Details

11.2.2 Innate Pharma SA Business Overview

11.2.3 Innate Pharma SA Natural Killer Cell Therapy Introduction

11.2.4 Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2019-2024)

11.2.5 Innate Pharma SA Recent Developments

11.3 Affimed

11.3.1 Affimed Company Details

11.3.2 Affimed Business Overview

11.3.3 Affimed Natural Killer Cell Therapy Introduction

11.3.4 Affimed Revenue in Natural Killer Cell Therapy Business (2019-2024)

11.3.5 Affimed Recent Developments

11.4 Chipscreen Biosciences

11.4.1 Chipscreen Biosciences Company Details

11.4.2 Chipscreen Biosciences Business Overview

11.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Introduction

11.4.4 Chipscreen Biosciences Revenue in Natural Killer Cell Therapy Business (2019-2024)

11.4.5 Chipscreen Biosciences Recent Developments

11.5 Glycostem Therapeutics

11.5.1 Glycostem Therapeutics Company Details

11.5.2 Glycostem Therapeutics Business Overview

11.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Introduction

11.5.4 Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2019-2024)

11.5.5 Glycostem Therapeutics Recent Developments

11.6 Fate Therapeutics

11.6.1 Fate Therapeutics Company Details

11.6.2 Fate Therapeutics Business Overview

11.6.3 Fate Therapeutics Natural Killer Cell Therapy Introduction

11.6.4 Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2019-2024)

11.6.5 Fate Therapeutics Recent Developments

11.7 Dragonfly Therapeutics

11.7.1 Dragonfly Therapeutics Company Details

11.7.2 Dragonfly Therapeutics Business Overview

11.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Introduction

11.7.4 Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2019-2024)

11.7.5 Dragonfly Therapeutics Recent Developments

11.8 Kiadis Pharma

11.8.1 Kiadis Pharma Company Details

11.8.2 Kiadis Pharma Business Overview

11.8.3 Kiadis Pharma Natural Killer Cell Therapy Introduction

11.8.4 Kiadis Pharma Revenue in Natural Killer Cell Therapy Business (2019-2024)

11.8.5 Kiadis Pharma Recent Developments

11.9 Nkarta Therapeutics

11.9.1 Nkarta Therapeutics Company Details

11.9.2 Nkarta Therapeutics Business Overview

11.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Introduction

11.9.4 Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2019-2024)

11.9.5 Nkarta Therapeutics Recent Developments

11.10 NantKwest

11.10.1 NantKwest Company Details

11.10.2 NantKwest Business Overview

11.10.3 NantKwest Natural Killer Cell Therapy Introduction

11.10.4 NantKwest Revenue in Natural Killer Cell Therapy Business (2019-2024)

11.10.5 NantKwest Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Nektar Therapeutics

Innate Pharma SA

Affimed NV

Chipscreen Biosciences

Glycostem Therapeutics

Fate Therapeutics

Dragonfly Therapeutics

Kiadis Pharma

Nkarta Therapeutics

NantKwest Inc

List of Tables

Table 1. Global Natural Killer Cell Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of NK Cell Therapies

Table 3. Key Players of NK Cell Directed Antibodies

Table 4. Global Natural Killer Cell Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Natural Killer Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Natural Killer Cell Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Natural Killer Cell Therapy Market Share by Region (2019-2024)

Table 8. Global Natural Killer Cell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Natural Killer Cell Therapy Market Share by Region (2025-2030)

Table 10. Natural Killer Cell Therapy Market Trends

Table 11. Natural Killer Cell Therapy Market Drivers

Table 12. Natural Killer Cell Therapy Market Challenges

Table 13. Natural Killer Cell Therapy Market Restraints

Table 14. Global Natural Killer Cell Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Natural Killer Cell Therapy Revenue Share by Players (2019-2024)

Table 16. Global Top Natural Killer Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapy as of 2023)

Table 17. Global Natural Killer Cell Therapy Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Natural Killer Cell Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Natural Killer Cell Therapy, Headquarters and Area Served

Table 20. Global Key Players of Natural Killer Cell Therapy, Product and Application

Table 21. Global Key Players of Natural Killer Cell Therapy, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Natural Killer Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Natural Killer Cell Therapy Revenue Market Share by Type (2019-2024)

Table 25. Global Natural Killer Cell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Natural Killer Cell Therapy Revenue Market Share by Type (2025-2030)

Table 27. Global Natural Killer Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Natural Killer Cell Therapy Revenue Share by Application (2019-2024)

Table 29. Global Natural Killer Cell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Natural Killer Cell Therapy Revenue Share by Application (2025-2030)

Table 31. North America Natural Killer Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Natural Killer Cell Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Natural Killer Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Natural Killer Cell Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Natural Killer Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Natural Killer Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Natural Killer Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Natural Killer Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Natural Killer Cell Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Natural Killer Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Natural Killer Cell Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Natural Killer Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Natural Killer Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Natural Killer Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Natural Killer Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Natural Killer Cell Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Natural Killer Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Natural Killer Cell Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Natural Killer Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Natural Killer Cell Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Natural Killer Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Natural Killer Cell Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Natural Killer Cell Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Natural Killer Cell Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Natural Killer Cell Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Natural Killer Cell Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 63. Nektar Therapeutics Company Details

Table 64. Nektar Therapeutics Business Overview

Table 65. Nektar Therapeutics Natural Killer Cell Therapy Product

Table 66. Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2019-2024) & (US$ Million)

Table 67. Nektar Therapeutics Recent Developments

Table 68. Innate Pharma SA Company Details

Table 69. Innate Pharma SA Business Overview

Table 70. Innate Pharma SA Natural Killer Cell Therapy Product

Table 71. Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2019-2024) & (US$ Million)

Table 72. Innate Pharma SA Recent Developments

Table 73. Affimed Company Details

Table 74. Affimed Business Overview

Table 75. Affimed Natural Killer Cell Therapy Product

Table 76. Affimed Revenue in Natural Killer Cell Therapy Business (2019-2024) & (US$ Million)

Table 77. Affimed Recent Developments

Table 78. Chipscreen Biosciences Company Details

Table 79. Chipscreen Biosciences Business Overview

Table 80. Chipscreen Biosciences Natural Killer Cell Therapy Product

Table 81. Chipscreen Biosciences Revenue in Natural Killer Cell Therapy Business (2019-2024) & (US$ Million)

Table 82. Chipscreen Biosciences Recent Developments

Table 83. Glycostem Therapeutics Company Details

Table 84. Glycostem Therapeutics Business Overview

Table 85. Glycostem Therapeutics Natural Killer Cell Therapy Product

Table 86. Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2019-2024) & (US$ Million)

Table 87. Glycostem Therapeutics Recent Developments

Table 88. Fate Therapeutics Company Details

Table 89. Fate Therapeutics Business Overview

Table 90. Fate Therapeutics Natural Killer Cell Therapy Product

Table 91. Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2019-2024) & (US$ Million)

Table 92. Fate Therapeutics Recent Developments

Table 93. Dragonfly Therapeutics Company Details

Table 94. Dragonfly Therapeutics Business Overview

Table 95. Dragonfly Therapeutics Natural Killer Cell Therapy Product

Table 96. Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2019-2024) & (US$ Million)

Table 97. Dragonfly Therapeutics Recent Developments

Table 98. Kiadis Pharma Company Details

Table 99. Kiadis Pharma Business Overview

Table 100. Kiadis Pharma Natural Killer Cell Therapy Product

Table 101. Kiadis Pharma Revenue in Natural Killer Cell Therapy Business (2019-2024) & (US$ Million)

Table 102. Kiadis Pharma Recent Developments

Table 103. Nkarta Therapeutics Company Details

Table 104. Nkarta Therapeutics Business Overview

Table 105. Nkarta Therapeutics Natural Killer Cell Therapy Product

Table 106. Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2019-2024) & (US$ Million)

Table 107. Nkarta Therapeutics Recent Developments

Table 108. NantKwest Company Details

Table 109. NantKwest Business Overview

Table 110. NantKwest Natural Killer Cell Therapy Product

Table 111. NantKwest Revenue in Natural Killer Cell Therapy Business (2019-2024) & (US$ Million)

Table 112. NantKwest Recent Developments

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Natural Killer Cell Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Natural Killer Cell Therapy Market Share by Type: 2023 VS 2030

Figure 3. NK Cell Therapies Features

Figure 4. NK Cell Directed Antibodies Features

Figure 5. Global Natural Killer Cell Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Natural Killer Cell Therapy Market Share by Application: 2023 VS 2030

Figure 7. Cancer Case Studies

Figure 8. Gastrointestinal Diseases Case Studies

Figure 9. Others Case Studies

Figure 10. Natural Killer Cell Therapy Report Years Considered

Figure 11. Global Natural Killer Cell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Natural Killer Cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Natural Killer Cell Therapy Market Share by Region: 2023 VS 2030

Figure 14. Global Natural Killer Cell Therapy Market Share by Players in 2023

Figure 15. Global Top Natural Killer Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapy as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Natural Killer Cell Therapy Revenue in 2023

Figure 17. North America Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Natural Killer Cell Therapy Market Share by Type (2019-2030)

Figure 19. North America Natural Killer Cell Therapy Market Share by Application (2019-2030)

Figure 20. North America Natural Killer Cell Therapy Market Share by Country (2019-2030)

Figure 21. United States Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Natural Killer Cell Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe Natural Killer Cell Therapy Market Share by Type (2019-2030)

Figure 25. Europe Natural Killer Cell Therapy Market Share by Application (2019-2030)

Figure 26. Europe Natural Killer Cell Therapy Market Share by Country (2019-2030)

Figure 27. Germany Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Natural Killer Cell Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China Natural Killer Cell Therapy Market Share by Type (2019-2030)

Figure 35. China Natural Killer Cell Therapy Market Share by Application (2019-2030)

Figure 36. Asia Natural Killer Cell Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia Natural Killer Cell Therapy Market Share by Type (2019-2030)

Figure 38. Asia Natural Killer Cell Therapy Market Share by Application (2019-2030)

Figure 39. Asia Natural Killer Cell Therapy Market Share by Region (2019-2030)

Figure 40. Japan Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Natural Killer Cell Therapy Market Share by Country (2019-2030)

Figure 50. Brazil Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Natural Killer Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Nektar Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2019-2024)

Figure 57. Innate Pharma SA Revenue Growth Rate in Natural Killer Cell Therapy Business (2019-2024)

Figure 58. Affimed Revenue Growth Rate in Natural Killer Cell Therapy Business (2019-2024)

Figure 59. Chipscreen Biosciences Revenue Growth Rate in Natural Killer Cell Therapy Business (2019-2024)

Figure 60. Glycostem Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2019-2024)

Figure 61. Fate Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2019-2024)

Figure 62. Dragonfly Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2019-2024)

Figure 63. Kiadis Pharma Revenue Growth Rate in Natural Killer Cell Therapy Business (2019-2024)

Figure 64. Nkarta Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2019-2024)

Figure 65. NantKwest Revenue Growth Rate in Natural Killer Cell Therapy Business (2019-2024)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-39R14639

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Cancer Early Detection and Diagnosis - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-37I14671

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global One-Stop Radiotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33G18542

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Immunotherapy for Neuroblastoma - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-1A14903

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Natural Killer Cell Therapy Market Insights, Forecast to 2030

Published Date: August 2024

Report Code: QYRE-Auto-38B12747

Global Natural Killer Cell Therapy Market Insights, Forecast to 2030

FEATURED COMPANIES

Natural Killer Cell Therapy Market Size

Natural Killer Cell Therapy Market

Scope of Natural Killer Cell Therapy Market Report

Chapter Outline

FAQ for this report

How fast is Natural Killer Cell Therapy Market growing?

What is the Natural Killer Cell Therapy Market size in 2030?

What is the Natural Killer Cell Therapy Market share by region?

What is the Natural Killer Cell Therapy Market share by application?

What is the market share of major companies in Natural Killer Cell Therapy Market?

Who are the main players in the Natural Killer Cell Therapy Market report?

What are the Application segmentation covered in the Natural Killer Cell Therapy Market report?

What are the Type segmentation covered in the Natural Killer Cell Therapy Market report?

FEATURED COMPANIES

RELATED REPORTS